MOKAN Wealth Management Inc. acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,950 shares of the company's stock, valued at approximately $541,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Creative Planning increased its position in shares of Colgate-Palmolive by 2.0% in the 3rd quarter. Creative Planning now owns 218,018 shares of the company's stock valued at $22,632,000 after purchasing an additional 4,372 shares during the last quarter. Swedbank AB grew its stake in shares of Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company's stock worth $306,246,000 after purchasing an additional 40,324 shares in the last quarter. Good Life Advisors LLC purchased a new position in Colgate-Palmolive in the third quarter valued at $436,000. Global Retirement Partners LLC grew its position in shares of Colgate-Palmolive by 16.5% in the 3rd quarter. Global Retirement Partners LLC now owns 7,466 shares of the company's stock valued at $775,000 after buying an additional 1,056 shares during the last quarter. Finally, Bleakley Financial Group LLC raised its stake in Colgate-Palmolive by 3.1% during the 3rd quarter. Bleakley Financial Group LLC now owns 22,376 shares of the company's stock worth $2,323,000 after acquiring an additional 674 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have issued reports on CL shares. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a report on Monday, February 3rd. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $101.16.
Get Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Price Performance
NYSE:CL traded up $0.99 during trading hours on Wednesday, hitting $87.38. The company's stock had a trading volume of 1,992,491 shares, compared to its average volume of 4,864,619. Colgate-Palmolive has a 52-week low of $83.70 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The business's 50-day moving average is $89.24 and its two-hundred day moving average is $96.11. The company has a market capitalization of $70.91 billion, a PE ratio of 24.82, a PEG ratio of 4.10 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm posted $0.87 earnings per share. As a group, research analysts anticipate that Colgate-Palmolive will post 3.76 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive's payout ratio is 56.82%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.